Data / Form D filings / EvolveImmune Therapeutics Holding Company, LLC
EvolveImmune Therapeutics Holding Company, LLC: Form D filings
EvolveImmune Therapeutics Holding Company, LLC, a biotechnology company in Branford, CT, filed 4 Form D notices with the SEC between 2020 and 2024. The latest, on November 1, 2024, reports $20 million sold of a $20 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 23 Business Park Drive, Branford, CT, 06405
- Phone
- (203) 858-7389
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1799828
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | New notice | $20,000,003 | $20,000,003 | 1 | Oct 22, 2024 | sec.gov | |
| Nov 16, 2023 | New notice | $57,398,375 | $37,398,371 | $20,000,004 | 9 | Nov 15, 2023 | sec.gov |
| Jan 19, 2023 | New notice | $26,000,000 | $10,827,780 | $15,172,220 | 8 | Jan 18, 2023 | sec.gov |
| Jan 17, 2020 | New notice | $35,099,985 | $17,549,992 | $17,549,993 | 8 | Jan 8, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Donmienne Leung | Director | |
| Ian Taylor | Director | |
| Derek Yoon | Director | |
| Stephen Bloch | Executive Officer, Director | |
| Jasmina Marjanovic | Director | |
| Denis Patrick | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Oct 28, 2024 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EvolveImmune Therapeutics Holding Company, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.